DNA methylation dynamics in blood after hematopoietic cell transplant.

Epigenetic deregulation is considered a common hallmark of cancer. Nevertheless, recent publications have demonstrated its association with a large array of human diseases. Here, we explore the DNA methylation dynamics in blood samples during hematopoietic cell transplant and how they are affected b...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ramon M Rodriguez, Beatriz Suarez-Alvarez, Rubén Salvanés, Manuel Muro, Pablo Martínez-Camblor, Enrique Colado, Miguel Alcoceba Sánchez, Marcos González Díaz, Agustin F Fernandez, Mario F Fraga, Carlos Lopez-Larrea
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/542b85c9329c4ca3b16eb83e6642f3cf
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:542b85c9329c4ca3b16eb83e6642f3cf
record_format dspace
spelling oai:doaj.org-article:542b85c9329c4ca3b16eb83e6642f3cf2021-11-18T07:56:23ZDNA methylation dynamics in blood after hematopoietic cell transplant.1932-620310.1371/journal.pone.0056931https://doaj.org/article/542b85c9329c4ca3b16eb83e6642f3cf2013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23451113/?tool=EBIhttps://doaj.org/toc/1932-6203Epigenetic deregulation is considered a common hallmark of cancer. Nevertheless, recent publications have demonstrated its association with a large array of human diseases. Here, we explore the DNA methylation dynamics in blood samples during hematopoietic cell transplant and how they are affected by pathophysiological events during transplant evolution. We analyzed global DNA methylation in a cohort of 47 patients with allogenic transplant up to 12 months post-transplant. Recipients stably maintained the donor's global methylation levels after transplant. Nonetheless, global methylation is affected by chimerism status. Methylation analysis of promoters revealed that methylation in more than 200 genes is altered 1 month post-transplant when compared with non-pathological methylation levels in the donor. This number decreased by 6 months post-transplant. Finally, we analyzed methylation in IFN-γ, FASL, IL-10, and PRF1 and found association with the severity of the acute graft-versus-host disease. Our results provide strong evidence that methylation changes in blood are linked to underlying physiological events and demonstrate that DNA methylation analysis is a viable strategy for the study of transplantation and for development of biomarkers.Ramon M RodriguezBeatriz Suarez-AlvarezRubén SalvanésManuel MuroPablo Martínez-CamblorPablo Martínez-CamblorEnrique ColadoMiguel Alcoceba SánchezMarcos González DíazAgustin F FernandezMario F FragaCarlos Lopez-LarreaPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 2, p e56931 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Ramon M Rodriguez
Beatriz Suarez-Alvarez
Rubén Salvanés
Manuel Muro
Pablo Martínez-Camblor
Pablo Martínez-Camblor
Enrique Colado
Miguel Alcoceba Sánchez
Marcos González Díaz
Agustin F Fernandez
Mario F Fraga
Carlos Lopez-Larrea
DNA methylation dynamics in blood after hematopoietic cell transplant.
description Epigenetic deregulation is considered a common hallmark of cancer. Nevertheless, recent publications have demonstrated its association with a large array of human diseases. Here, we explore the DNA methylation dynamics in blood samples during hematopoietic cell transplant and how they are affected by pathophysiological events during transplant evolution. We analyzed global DNA methylation in a cohort of 47 patients with allogenic transplant up to 12 months post-transplant. Recipients stably maintained the donor's global methylation levels after transplant. Nonetheless, global methylation is affected by chimerism status. Methylation analysis of promoters revealed that methylation in more than 200 genes is altered 1 month post-transplant when compared with non-pathological methylation levels in the donor. This number decreased by 6 months post-transplant. Finally, we analyzed methylation in IFN-γ, FASL, IL-10, and PRF1 and found association with the severity of the acute graft-versus-host disease. Our results provide strong evidence that methylation changes in blood are linked to underlying physiological events and demonstrate that DNA methylation analysis is a viable strategy for the study of transplantation and for development of biomarkers.
format article
author Ramon M Rodriguez
Beatriz Suarez-Alvarez
Rubén Salvanés
Manuel Muro
Pablo Martínez-Camblor
Pablo Martínez-Camblor
Enrique Colado
Miguel Alcoceba Sánchez
Marcos González Díaz
Agustin F Fernandez
Mario F Fraga
Carlos Lopez-Larrea
author_facet Ramon M Rodriguez
Beatriz Suarez-Alvarez
Rubén Salvanés
Manuel Muro
Pablo Martínez-Camblor
Pablo Martínez-Camblor
Enrique Colado
Miguel Alcoceba Sánchez
Marcos González Díaz
Agustin F Fernandez
Mario F Fraga
Carlos Lopez-Larrea
author_sort Ramon M Rodriguez
title DNA methylation dynamics in blood after hematopoietic cell transplant.
title_short DNA methylation dynamics in blood after hematopoietic cell transplant.
title_full DNA methylation dynamics in blood after hematopoietic cell transplant.
title_fullStr DNA methylation dynamics in blood after hematopoietic cell transplant.
title_full_unstemmed DNA methylation dynamics in blood after hematopoietic cell transplant.
title_sort dna methylation dynamics in blood after hematopoietic cell transplant.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/542b85c9329c4ca3b16eb83e6642f3cf
work_keys_str_mv AT ramonmrodriguez dnamethylationdynamicsinbloodafterhematopoieticcelltransplant
AT beatrizsuarezalvarez dnamethylationdynamicsinbloodafterhematopoieticcelltransplant
AT rubensalvanes dnamethylationdynamicsinbloodafterhematopoieticcelltransplant
AT manuelmuro dnamethylationdynamicsinbloodafterhematopoieticcelltransplant
AT pablomartinezcamblor dnamethylationdynamicsinbloodafterhematopoieticcelltransplant
AT pablomartinezcamblor dnamethylationdynamicsinbloodafterhematopoieticcelltransplant
AT enriquecolado dnamethylationdynamicsinbloodafterhematopoieticcelltransplant
AT miguelalcocebasanchez dnamethylationdynamicsinbloodafterhematopoieticcelltransplant
AT marcosgonzalezdiaz dnamethylationdynamicsinbloodafterhematopoieticcelltransplant
AT agustinffernandez dnamethylationdynamicsinbloodafterhematopoieticcelltransplant
AT marioffraga dnamethylationdynamicsinbloodafterhematopoieticcelltransplant
AT carloslopezlarrea dnamethylationdynamicsinbloodafterhematopoieticcelltransplant
_version_ 1718422728766128128